Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 362.69B, Merck(MRK) trades at $146.87. The stock has a price-to-earnings ratio of 151.19 and currently yields dividends of 2.30%.
As of 2026-11-12, Merck(MRK) stock has fluctuated between $145.30 and $147.61. The current price stands at $146.87, placing the stock +1.1% above today's low and -0.5% off the high.
The Merck(MRK)'s current trading volume is 6.41M, compared to an average daily volume of 9.32M.
During the past year, Merck(MRK) stock moved between $90.90 at its lowest and $156.92 at its peak.
During the past year, Merck(MRK) stock moved between $90.90 at its lowest and $156.92 at its peak.
MRK News
...
It sounds nuts, but SoFi is giving new Active Invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for y...
The next wave of U.S. drug-price negotiations could put billions of dollars in pharmaceutical revenue under pressure, with Eli Lilly and Co (NYSE:LLY), Gilead S...
Analyst ratings
70%
of 30 ratingsMore MRK News
has delivered a strong multi‑year share price run, and with the stock last closing at US$148.76, the live question is whether that level is supported by the cas...
Merck (MRK) is back in focus after a run of late October oncology readouts, including Phase 3 wins for KEYTRUDA and sacituzumab tirumotecan in endometrial cance...
Merck’s (MRK Quick QuoteMRK - Free Report) stock has been trading above its 200-day simple moving average (SMA) for over a year now, while it moved above...
Merck (NYSE:MRK) reported new Phase 3 data for oncology programs including KEYTRUDA and an mRNA melanoma therapy on 5 November 2026. KEYNOTE-C93 showed KEYTRUD...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.